Table 6.
| US | EU | UN | Intensity | Economic | Unilateral | Plurilateral | |
|---|---|---|---|---|---|---|---|
| DPT Vaccination | |||||||
| Main (Table 2) | – | – | / | – | – | – | / |
| Health Spending PC (A1) | – | – | / | – | – | – | / |
| Health GDP (A5) | – | – | / | – | – | – | / |
| Low to Lower-middle (A9) | – | – | / | – | – | – | – |
| Upper middle to high (A13) | / | / | – | / | / | / | / |
| Lagged (A17) | – | – | / | -^ | -^ | – | -^ |
| Control + Treated (A21) | – | – | / | – | – | – | / |
| FGLS (A25) | – | – | / | – | – | – | / |
| PCSE (A29) | – | – | / | – | – | – | / |
| 2SLS - UNGA (A33) | – | – | – | – | – | – | / |
| 2SLS - UNSC (A37) | – | – | – | – | – | – | / |
| System GMM (A41) | – | – | / | – | – | – | / |
| Hepatitis B Vaccination | |||||||
| Main (Table 3) | – | / | / | / | – | / | – |
| Health Spending PC (A2) | – | / | + | / | – | / | – |
| Health GDP (A6) | – | – | + | / | – | / | – |
| Low to Lower-middle (A10) | – | – | / | / | – | / | – |
| Upper middle to high (A14 | / | / | – | / | + | / | / |
| Lagged (A18) | / | / | / | / | -^ | / | -^ |
| Control + Treated (A22) | – | / | / | / | – | / | – |
| FGLS (A26) | – | / | / | / | – | / | / |
| PCSE (A30) | – | / | / | / | – | / | / |
| 2SLS - UNGA (A34) | / | – | – | – | / | / | / |
| 2SLS - UNSC (A38) | – | – | – | – | – | – | / |
| System GMM (A42) | / | / | / | / | / | – | / |
| Measles Vaccination | |||||||
| Main (Table 4) | – | – | – | – | – | – | / |
| Health Spending PC (A3) | – | – | / | – | – | – | / |
| Health GDP (A7) | – | – | / | – | – | – | / |
| Low to Lower-middle (A11) | – | – | – | – | – | – | / |
| Upper middle to high (A15) | + | / | – | / | / | – | – |
| Lagged (A19) | – | – | – | – | – | – | / |
| Control + Treated (A23) | – | – | – | – | – | – | / |
| FGLS (A27) | – | – | – | – | – | – | / |
| PCSE (A31) | – | – | – | – | – | – | / |
| 2SLS - UNGA (A35) | – | – | – | – | – | – | / |
| 2SLS - UNSC (A39) | – | – | – | – | – | – | / |
| System GMM (A43) | – | / | / | – | – | – | / |
| Polio Vaccination | |||||||
| Main (Table 5) | / | – | / | – | – | – | – |
| Health Spending PC (A4) | / | – | / | – | – | – | – |
| Health GDP (A8) | / | – | / | – | – | – | – |
| Low to Lower-middle (A12) | / | – | / | – | – | – | – |
| Upper middle to high (A16) | / | / | – | / | / | – | / |
| Lagged (A20) | / | -^ | / | -^ | -^ | -^ | -^ |
| Control + Treated (A24) | – | – | / | – | – | – | – |
| FGLS (A28) | / | – | / | – | – | – | – |
| PCSE (A32) | / | – | / | – | – | – | – |
| 2SLS - UNGA (A36) | – | – | – | – | – | – | / |
| 2SLS - UNSC (A40) | – | – | – | – | – | – | / |
| System GMM (A44) | / | – | / | – | – | – | / |
“+” denotes a significant positive association.
“-” denotes a significant negative association.
“/” denotes no significant association.
“-^” denotes that not all lagged years show a negative association.